TGFBR1 Antikörper (AA 145-172)

Produktnummer ABIN3029223

Produktdetails anti-TGFBR1 Antikörper

Target: TGFBR1 (Transforming Growth Factor, beta Receptor 1 (TGFBR1))

Bindungsspezifität: AA 145-172

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TGFBR1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Kreuzreaktivität (Details): Expected species reactivity: Rat, Bovine, Pig

Aufreinigung: Antigen affinity purified

Immunogen: A portion of amino acids 145-172 from the human protein was used as the immunogen for this TGFBR1 antibody.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: Titration of the TGFBR1 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot the TGFBR1 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Details zu TGFBR1

Target: TGFBR1 (Transforming Growth Factor, beta Receptor 1 (TGFBR1))

Andere Bezeichnung: TGFBR1 (TGFBR1 Produkte)

Synonyme: AAT5 antikoerper, ACVRLK4 antikoerper, ALK-5 antikoerper, ALK5 antikoerper, LDS1A antikoerper, LDS2A antikoerper, MSSE antikoerper, SKR4 antikoerper, TGFR-1 antikoerper, aat5 antikoerper, acvrlk4 antikoerper, alk-5 antikoerper, alk5 antikoerper, lds1a antikoerper, lds2a antikoerper, skr4 antikoerper, tgfr-1 antikoerper, TGFBR1 antikoerper, x-trr1 antikoerper, AU017191 antikoerper, Alk-5 antikoerper, TbetaR-I antikoerper, TbetaRI antikoerper, Alk5 antikoerper, Skr4 antikoerper, Tgfr-1 antikoerper, tbetaR-I antikoerper, tgfbr1 antikoerper, zgc:123263 antikoerper, transforming growth factor beta receptor 1 antikoerper, transforming growth factor beta receptor I antikoerper, transforming growth factor beta receptor I S homeolog antikoerper, transforming growth factor, beta receptor I antikoerper, transforming growth factor, beta receptor 1 antikoerper, transforming growth factor, beta receptor 1 a antikoerper, TGFBR1 antikoerper, tgfbr1 antikoerper, tgfbr1.S antikoerper, Tgfbr1 antikoerper, tgfbr1a antikoerper

Hintergrund: Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 Molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation.

UniProt: P36897

Pathways: Growth Factor Binding